Screener
United Therapeutics UTHR Net Income Loss
Net Income Loss at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's net income loss?
- United Therapeutics (UTHR) reported net income loss of $333M in Q2 2026.
- How has United Therapeutics's net income loss changed year-over-year?
- United Therapeutics's net income loss increased by 7.6% year-over-year, from $309.5M to $333M.
- What is the long-term trend for United Therapeutics's net income loss?
- Over 4 years (2021 to 2025), United Therapeutics's net income loss has grown at a 29.4% compound annual growth rate (CAGR), from $475.8M to $1.33B.
- What does net income loss mean?
- Net Income Loss as reported by United Therapeutics Corp.
Ask your AI about United Therapeutics's net income loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude